Verastem names Daniel Paterson COO
This article was originally published in Scrip
Verastem, a company focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, has appointed Daniel Paterson, current chief business officer, to the role of chief operating officer. Mr Paterson has been at Verastem since 2012, initially joining the company as a consultant. Prior to working at Verastem, he was COO of On-Q-ity following its acquisition of The DNA Repair Company where he was the CEO and president from 2006.
You may also be interested in...
A rush in the 2010s of high-tech and digital companies focused on women’s health and wellbeing are maturing, adding weight to the more traditional women's health market that has struggled to get attention from investors in the past.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
A selection of articles you might have missed from September 2020, including exclusive interviews with industry leaders and a review of value-based contract approaches in the US.